HomeCompareTKKYY vs PFE

TKKYY vs PFE: Dividend Comparison 2026

TKKYY yields 2.11% · PFE yields 6.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 TKKYY wins by $81.35M in total portfolio value
10 years
TKKYY
TKKYY
● Live price
2.11%
Share price
$7.88
Annual div
$0.17
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$81.40M
Annual income
$74,610,734.38
Full TKKYY calculator →
PFE
Pfizer Inc.
● Live price
6.13%
Share price
$28.08
Annual div
$1.72
5Y div CAGR
13.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$49.6K
Annual income
$26,258.71
Full PFE calculator →

Portfolio growth — TKKYY vs PFE

📍 TKKYY pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodTKKYYPFE
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, TKKYY + PFE cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
TKKYY pays
PFE pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

TKKYY
Annual income on $10K today (after 15% tax)
$179.57/yr
After 10yr DRIP, annual income (after tax)
$63,419,124.22/yr
PFE
Annual income on $10K today (after 15% tax)
$520.66/yr
After 10yr DRIP, annual income (after tax)
$22,319.90/yr
At 15% tax rate, TKKYY beats the other by $63,396,804.32/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of TKKYY + PFE for your $10,000?

TKKYY: 50%PFE: 50%
100% PFE50/50100% TKKYY
Portfolio after 10yr
$40.72M
Annual income
$37,318,496.55/yr
Blended yield
91.64%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PFE right now

TKKYY
No analyst data
Altman Z
1.2
Piotroski
5/9
PFE
Analyst Ratings
16
Buy
22
Hold
1
Sell
Consensus: Hold
Price Target
$27.50
-2.1% upside vs current
Range: $24.00 — $35.00
Altman Z
2.0
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

TKKYY buys
0
PFE buys
8
PoliticianChamberTickerTypeAmountDate
Gilbert Cisneros🏢 House$PFE▲ Buy$1,001 - $15,0002026-02-10
Susan M. Collins🏛 Senate$PFE▲ Buy$15,001 - $50,0002026-02-03
James French Hill🏢 House$PFE▼ Sell$100,001 - $250,0002025-12-31
Gilbert Cisneros🏢 House$PFE▼ Sell$1,001 - $15,0002025-12-19
Ro Khanna🏢 House$PFE▼ Sell$1,001 - $15,0002025-09-15
Ro Khanna🏢 House$PFE▼ Sell$1,001 - $15,0002025-09-05
Gilbert Cisneros🏢 House$PFE▼ Sell$1,001 - $15,0002025-08-05
Lisa McClain🏢 House$PFE▲ Buy$1,001 - $15,0002025-07-16
Ron Wyden🏛 Senate$PFE▼ Sell$1,001 - $15,0002025-06-03
Ron Wyden🏛 Senate$PFE▼ Sell$1,001 - $15,0002025-06-03
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricTKKYYPFE
Forward yield2.11%6.13%
Annual dividend / share$0.17$1.72
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%13.2%
Portfolio after 10y$81.40M$49.6K
Annual income after 10y$74,610,734.38$26,258.71
Total dividends collected$80.86M$58.3K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: TKKYY vs PFE ($10,000, DRIP)

YearTKKYY PortfolioTKKYY Income/yrPFE PortfolioPFE Income/yrGap
1← crossover$11,123$422.51$9,153$693.39+$2.0KTKKYY
2$12,779$878.39$8,593$849.25+$4.2KTKKYY
3$15,560$1,886.45$8,336$1,066.78+$7.2KTKKYY
4$20,943$4,293.40$8,437$1,384.80+$12.5KTKKYY
5$33,210$10,801.06$9,013$1,875.40+$24.2KTKKYY
6$67,549$32,014.19$10,306$2,680.72+$57.2KTKKYY
7$193,990$121,712.94$12,820$4,101.38+$181.2KTKKYY
8$860,917$653,346.76$17,673$6,826.70+$843.2KTKKYY
9$6,340,822$5,419,641.74$27,543$12,591.86+$6.31MTKKYY
10$81,395,414$74,610,734.38$49,560$26,258.71+$81.35MTKKYY

TKKYY vs PFE: Complete Analysis 2026

TKKYYStock

Türkiye Sise Ve Cam Fabrikalari A.S. manufactures and sells glass products in Turkey, the United States, Russia, Ukraine, Georgia, Europe, and internationally. It operates through six segments: Architectural, Automotive, Glassware, Glass Packaging, Chemicals, and Others. The company offers architectural glass products, such as flat, patterned, mirror, laminated, coated, solar power, and white goods glass products; automotive glass products; energy glass products; and home appliance glass products. It also designs, produces, and sells glassware; produces and sells glass packaging products for various industries, including food, beverages, pharmaceuticals, and cosmetics; and retails glass, ceramic, porcelain, and wood and steel tableware and kitchenware, and home decoration items under the Life and Boutique concepts through 51 Pasabahçe stores located in Turkey and international markets, as well as through online sales channels. In addition, the company produces and sells soda ash and chromium chemicals, glass fiber, raw materials, vitamin K3 derivatives, sodium dichromate, basic chromium sulfate, and sodium metabisulfite to food, textiles, mining, water treatment, construction chemicals, and leather industries; automotive and encapsulated glasses; and glasses for light and heavy-duty commercial vehicles. Further, it is involved in the mining of silica sand, feldspar, limestone, dolomite, kaolin, and quartzite; generation and sale of electricity; wholesaling and retail of natural gas; glass recycling and waste collection activities; and production and trading of soda goods, as well as offers finance and investment, and insurance agency services. The company was founded in 1935 and is headquartered in Istanbul, Turkey. Türkiye Sise Ve Cam Fabrikalari A.S. operates as a subsidiary of Türkiye Is Bankasi A.S.

Full TKKYY Calculator →

PFEHealthcare

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Full PFE Calculator →
📬

Get this TKKYY vs PFE comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

TKKYY vs SCHDTKKYY vs JEPITKKYY vs OTKKYY vs KOTKKYY vs MAINTKKYY vs JNJTKKYY vs MRKTKKYY vs ABBV

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.